METHODS	One hundred sixty-four patients with regular , painful , primary OA of the knee ( n = 114 ) or hip ( n = 50 ) entered a prospective , randomized , double-blind , placebo-controlled , parallel-group , multicenter trial with a 6-month treatment period and a 2-month posttreatment followup .\